focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,178.00
Bid: 12,178.00
Ask: 12,182.00
Change: 82.00 (0.68%)
Spread: 4.00 (0.033%)
Open: 12,150.00
High: 12,266.00
Low: 12,134.00
Prev. Close: 12,096.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UPDATE 1-'The best shield': Peru launches inoculation drive with Sinopharm vaccine

Wed, 10th Feb 2021 01:13

(Adds comment from Peru's president)

By Marco Aquino

LIMA, Feb 9 (Reuters) - Peru launched its COVID-19
vaccination campaign on Tuesday with newly arrived doses of
China's Sinopharm vaccine, as the South American
country struggles to control a fierce second wave of infections
that has forced a lockdown in the capital, Lima.

Health officials kicked off the program in the intensive
care unit of Lima's Arzobispo Loayza Hospital, authorities said,
where medical staff were slated to receive the first of 300,000
doses delivered on Sunday by Sinopharm Group Co Ltd.

Peruvian President Francisco Sagasti was vaccinated later in
the day and urged vaccine skeptics to get inoculated. A survey
by Ipsos Peru last month showed 48% of Peruvians would refuse to
be vaccinated, citing fears of side effects.

"Do not be afraid of the vaccine. The vaccine is the best
shield," Sagasti said in a brief speech shortly before receiving
his shot at a military hospital.

"We are betting as much as possible that all Peruvians can
be vaccinated this year," he added.

Coronavirus infections have spiked in Peru this year,
bringing hospitals and the country's ailing healthcare system to
the brink of collapse. Authorities have detected both the
Brazilian and British variants of the virus, officials said.

Peru, which was mired in a political crisis last year,
initially lagged behind its wealthier neighbors in locking down
COVID-19 vaccine deals.

The Andean nation has since signed agreements with
U.S.-based Pfizer Inc, British-Swedish firm AstraZeneca
and Sinopharm, and is also slated to receive vaccines
through the World Health Organization's COVAX program.

The country plans to begin immediately inoculating a
million health officials, police and military personnel, among
others, the government said, in a first round of vaccinations
that will likely run through March.

Peru will then vaccinate 5.3 million elderly people, those
suffering from pre-existing conditions and its native
communities.

Peru's deal with Sinopharm guarantees the country 38 million
doses. A fresh batch of 700,000 doses is expected to arrive on
Sunday, health officials said.

Peru has tallied almost 1.2 million cases of COVID-19 and
42,400 deaths.
(Reporting by Marco Aquino and Reuters TV; Writing by Dave
Sherwood; Editing by Paul Simao and Peter Cooney)

More News
12 Dec 2023 12:07

London midday: FTSE still firmer ahead of US inflation print

(Sharecast News) - London's markets remained relatively stable by midday on Tuesday, with the top-flight index still in the green after fresh jobs data showed a slowdown in wage growth.

Read more
12 Dec 2023 10:08

AstraZeneca buys respiratory vaccine developer Icosavax in $1.1 bln deal

Dec 12 (Reuters) - AstraZeneca said on Tuesday it had agreed to buy respiratory syncytial virus (RSV) vaccine developer Icosavax in a deal valued at up to $1.1 billion.

Read more
12 Dec 2023 08:53

LONDON MARKET OPEN: FTSE 100 opens higher ahead of US CPI

(Alliance News) - Stock prices in London opened higher on Tuesday, as investors digest the latest UK unemployment data, before turning their eyes to US inflation this afternoon.

Read more
12 Dec 2023 08:37

AstraZeneca acquires vaccine developer Icosavax for USD1.1 billion

(Alliance News) - AstraZeneca PLC confirmed on Tuesday that it will buy Icosavax Inc, boosting its vaccine portfolio with an "innovative" treatment for respiratory viruses.

Read more
12 Dec 2023 07:39

LONDON BRIEFING: UK unemployment unchanged at 4.2%; eyes on US CPI

(Alliance News) - Stocks in London are called to open higher, as investors digest the latest UK unemployment data, before turning their heads to US inflation.

Read more
12 Dec 2023 07:16

AstraZeneca to buy US vaccine maker Icosavax for up to $1.1bn

(Sharecast News) - AstraZeneca said on Tuesday that it has agreed to buy Icosavax - a US-based clinical-stage biopharmaceutical company - for up to $1.1bn.

Read more
12 Dec 2023 02:00

UK companies pause China investment decisions as economy slows, survey shows

BEIJING, Dec 12 (Reuters) - A slowdown in both the Chinese and global economies is the biggest issue affecting British firms in the world's second-largest economy, beating geopolitical concerns and market access barriers, according to the British Chamber of Commerce in China.

Read more
11 Dec 2023 08:15

AstraZeneca says danicopan tests well as blood disorder treatment

(Alliance News) - AstraZeneca PLC on Monday reported "positive results" from a test of danicopan for the treatment of paroxysmal nocturnal haemoglobinuria, or PNH, a rare and severe blood disorder.

Read more
5 Dec 2023 10:02

LONDON BROKER RATINGS: Goldman lifts Landsec and British Land

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Monday:

Read more
1 Dec 2023 08:52

LONDON MARKET OPEN: Miners give FTSE 100 boost thanks to China PMI

(Alliance News) - Stock prices in London opened higher on Friday, with the FTSE 100 boosted by mining stocks.

Read more
1 Dec 2023 08:33

AstraZeneca discontinues two phase III evidence trials for Lokelma

(Alliance News) - AstraZeneca on Friday said it has decided to discontinue the Stabilize-CKD and Dialize-outcomes phase III trials for Lokelma, citing increased enrolment timelines.

Read more
1 Dec 2023 08:01

AstraZeneca calls off two phase III trials into hyperkalaemia treatment

(Sharecast News) - Drugmaker AstraZeneca has called off two phase III trials on its hyperkalaemia treatment after a series of logistical challenges.

Read more
1 Dec 2023 07:41

LONDON BRIEFING: Stocks called higher; UK house prices fall annually

(Alliance News) - Stocks in London are called to open higher on Friday, following data from Nationwide showing that the annual pace of UK house price decline slowed in November.

Read more
27 Nov 2023 16:12

London close: Stocks start week in subdued state

(Sharecast News) - London's financial markets saw a somewhat subdued performance on Monday, as concerns regarding the Chinese economy cast a shadow over investor sentiment.

Read more
27 Nov 2023 09:20

LONDON BROKER RATINGS: Peel, Numis up Rightmove; Goldman cuts Entain

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.